<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Chem.</journal-id>
<journal-title>Frontiers in Chemistry</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Chem.</abbrev-journal-title>
<issn pub-type="epub">2296-2646</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">679592</article-id>
<article-id pub-id-type="doi">10.3389/fchem.2021.679592</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Chemistry</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Bioactive &#x3b1;-Pyrone Derivatives from the Endophytic Fungus <italic>Diaporthe</italic> sp. CB10100 as Inducible Nitric Oxide Synthase Inhibitors</article-title>
<alt-title alt-title-type="left-running-head">Pu et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Bioactive &#x3b1;<italic>-</italic>Pyrone Derivatives against iNOS</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pu</surname>
<given-names>Hong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1264514/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Jianxin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Wang</surname>
<given-names>Yeji</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Peng</surname>
<given-names>Yuhui</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zheng</surname>
<given-names>Wanying</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Tang</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Hui</surname>
<given-names>Boping</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nie</surname>
<given-names>Chunmei</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Xueshuang</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Duan</surname>
<given-names>Yanwen</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1177463/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Huang</surname>
<given-names>Yong</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/545568/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<label>
<sup>1</sup>
</label>Xiangya International Academy of Translational Medicine, Central South University, <addr-line>Changsha</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<label>
<sup>2</sup>
</label>School of Pharmaceutical Sciences, Hunan University of Medicine, <addr-line>Huaihua</addr-line>, <country>China</country>
</aff>
<aff id="aff3">
<label>
<sup>3</sup>
</label>Hunan Provincial Key Laboratory for Synthetic Biology of Traditional Chinese Medicine, Hunan University of Medicine, <addr-line>Huaihua</addr-line>, <country>China</country>
</aff>
<aff id="aff4">
<label>
<sup>4</sup>
</label>Hunan Engineering Research Center of Combinatorial Biosynthesis and Natural Product Drug Discover, <addr-line>Changsha</addr-line>, <country>China</country>
</aff>
<aff id="aff5">
<label>
<sup>5</sup>
</label>National Engineering Research Center of Combinatorial Biosynthesis for Drug Discovery, <addr-line>Changsha</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/411470/overview">Zhendong Jin</ext-link>, The University of Iowa, United&#x20;States</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1280745/overview">Senhua Chen</ext-link>, Sun Yat-Sen University, China</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/414064/overview">Yuguo Du</ext-link>, Chinese Academy of Sciences (CAS), China</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yong Huang, <email>jonghuang@csu.edu.cn</email>; Yanwen Duan, <email>ywduan66@sina.com</email> </corresp>
<fn fn-type="other">
<p>This article was submitted to Organic Chemistry, a section of the journal Frontiers in Chemistry</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>18</day>
<month>05</month>
<year>2021</year>
</pub-date>
<pub-date pub-type="collection">
<year>2021</year>
</pub-date>
<volume>9</volume>
<elocation-id>679592</elocation-id>
<history>
<date date-type="received">
<day>12</day>
<month>03</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>28</day>
<month>04</month>
<year>2021</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2021 Pu, Liu, Wang, Peng, Zheng, Tang, Hui, Nie, Huang, Duan and Huang.</copyright-statement>
<copyright-year>2021</copyright-year>
<copyright-holder>Pu, Liu, Wang, Peng, Zheng, Tang, Hui, Nie, Huang, Duan and Huang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Inducible nitric oxide synthase (iNOS) produces NO from <sc>l</sc>-arginine and plays critical roles in inflammation and immune activation. Selective and potent iNOS inhibitors may be potentially used in many indications, such as rheumatoid arthritis, pain, and neurodegeration. In the current study, five new compounds, including a dibenzo-&#x3b1;- pyrone derivative ellagic acid B (<bold>5</bold>) and four &#x3b1;<italic>-</italic>pyrones diaporpyrone A&#x2013;D (<bold>9&#x2013;12</bold>), together with three known compounds (<bold>6</bold>&#x2013;<bold>8</bold>), were isolated from the endophytic fungus <italic>Diaporthe</italic> sp. CB10100. The structures of these new natural products were unambiguously elucidated using NMR, HRESIMS or electronic circular dichroism calculations. Ellagic acid B (<bold>5</bold>) features a tetracyclic 6/6/6/6 ring system with a fused 2<italic>H</italic>-chromene, which is different from ellagic acid (<bold>4</bold>) with a fused 2<italic>H</italic>-chromen-2-one. Both 2-hydroxy-alternariol (<bold>6</bold>) and alternariol (<bold>7</bold>) reduced the expression of iNOS at protein levels in a dose-dependent manner, using a lipopolysaccharide (LPS)-induced RAW264.7 cell models. Also, they decreased the protein expression levels of pro-inflammatory cytokines, such as tumor necrosis factor-&#x3b1;, interleukin-6 and monocyte chemotactic protein 1. Importantly, <bold>6</bold> and <bold>7</bold> significantly reduced the production of NO as low as 10&#xa0;&#x3bc;M in LPS-induced RAW264.7 cells. Molecular docking of <bold>6</bold> and <bold>7</bold> to iNOS further suggests that both of them may interact with iNOS. Our study suggests that <bold>6</bold> and <bold>7</bold>, as well as the alternariol scaffold may be further developed as potential iNOS inhibitors.</p>
</abstract>
<kwd-group>
<kwd>endophytic fungus</kwd>
<kwd>
<italic>Diaporthe</italic> sp.</kwd>
<kwd>&#x3b1;-pyrone</kwd>
<kwd>anti-inflammation</kwd>
<kwd>inducible nitric oxide synthase</kwd>
<kwd>NO</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>Inflammation plays important roles in the occurring and development of many diseases, including rheumatoid arthritis (RA) (<xref ref-type="bibr" rid="B11">Choy and Panayi, 2001</xref>), osteoarthritis (OA) (<xref ref-type="bibr" rid="B1">Ahmad et&#x20;al., 2020</xref>), diabetes (<xref ref-type="bibr" rid="B36">Purkayastha and Cai, 2015</xref>), and cancers (<xref ref-type="bibr" rid="B48">Zhong et&#x20;al., 2016</xref>). When inflammation occurs, excessive inflammatory mediators are produced by inducible nitric oxide synthase (iNOS) or cyclooxygenase-2 (COX-2), such as NO and prostaglandin E2 (PGE<sub>2</sub>) (<xref ref-type="bibr" rid="B44">Yu et&#x20;al., 2019</xref>). Non-steroidal anti-inflammatory drugs (NSAIDs) and steroid hormone glucocorticoids are both used for the treatment of inflammation, despite serious side effects (<xref ref-type="bibr" rid="B5">Buchman, 2001</xref>; <xref ref-type="bibr" rid="B39">Salvo et&#x20;al., 2011</xref>). iNOS is a mammalian protein composed of a C-terminal reductase and an N-terminal oxygenase domain, which produces micromolar NO by oxidizing <sc>l</sc>-arginine to <sc>l</sc>-citrulline in the presence of bacterial lipopolysaccharide (LPS) and/or proinflammatory cytokines. A considerable number of iNOS inhibitors, such as arginine derivatives, pyrimidines and aminopyrimidines, as well as aliphatic, aromatic, and cyclic amidines, have been developed (<xref ref-type="bibr" rid="B12">Cinelli et&#x20;al., 2020</xref>). Although many of them showed promise in the treatment of arthritis or inflammatory and neuropathic pain in animal models, there are no iNOS inhibitors on the market. Therefore, there is strong need to discover new iNOS inhibitors as anti-inflammation agents.</p>
<p>&#x3b1;-Pyrone (<bold>1</bold>, <xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>) is an aromatic unsaturated lactone and an important sub-structure of various natural products with interesting biological activities (<xref ref-type="bibr" rid="B34">Mcglacken and Fairlamb, 2005</xref>). For example, dothideopyrone F (<bold>2</bold>) inhibited NO production in LPS-induced BV2 cells and diminished the protein expression levels of iNOS and COX-2 (<xref ref-type="bibr" rid="B26">Kim et&#x20;al., 2018</xref>). In addition, natural products with &#x3b1;-pyrone sub-structure have antibacterial (<xref ref-type="bibr" rid="B46">Zhang et&#x20;al., 2013</xref>), anti-influenza A virus (<xref ref-type="bibr" rid="B19">Hou et&#x20;al., 2018</xref>), and anti-HIV (<xref ref-type="bibr" rid="B2">Appendino et&#x20;al., 2007</xref>) activities. Some of them are signal molecules (<xref ref-type="bibr" rid="B3">Brachmann et&#x20;al., 2013</xref>), while some are also cytotoxic agents against tumor cells (<xref ref-type="bibr" rid="B38">Rivera-Ch&#xe1;vez et&#x20;al., 2019</xref>; <xref ref-type="bibr" rid="B49">Zhu et&#x20;al., 2019</xref>). In particular, dibenzo-&#x3b1;-pyrone (<bold>3</bold>) belongs to a significant group of heptaketide coumarin metabolites that have a fused tricyclic core (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>), commonly identified from fungi, bacteria, and plants (<xref ref-type="bibr" rid="B31">Lai et&#x20;al., 2016</xref>). Many of them also display diverse biological activities including cytotoxicity and anti-inflammatory activity (<xref ref-type="bibr" rid="B33">Mao et&#x20;al., 2014</xref>). For example, ellagic acid <bold>(4)</bold>, found in medicinal plants, vegetables and fruits, exhibits impressive anti-inflammatory and anti-diabetic activities (<xref ref-type="bibr" rid="B37">R&#xed;os et&#x20;al., 2018</xref>). It is widely used in skin care products because of its anti-oxidation effect and skin protection effects.</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>Structures of compounds <bold>1&#x2013;12. (A)</bold> The structures of dibenzo-&#x3b1;-pyrones, &#x3b1;-pyrone, and their derivatives. <bold>(B)</bold> Compounds isolated from endophilic fungus strain <italic>Diaporthe</italic> sp. CB10100.</p>
</caption>
<graphic xlink:href="fchem-09-679592-g001.tif"/>
</fig>
<p>Sinomenine (<xref ref-type="sec" rid="s9">Supplementary Figure S1</xref>), a tetrahydroisoquinoline-type alkaloid isolated from the medicinal plant of <italic>Sinomenium acutum</italic> (Thunb.) (&#x201c;&#x9752;&#x98ce;&#x85e4;&#x201d; in Chinese), has strong anti-inflammatory effects and is used in China to treat RA for many years (<xref ref-type="bibr" rid="B47">Zhao et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B43">Wang et&#x20;al., 2019</xref>). To our knowledge, there are few reports of endophytes and their natural products from <italic>S. acutum</italic>. Since endophytes from medical plants are attractive sources of bioactive natural products, we initiated an endeavor to isolate natural products from endophytes colonized in the stem and root of <italic>S. acutum</italic>, in our continuous search for new bioactive metabolites of microorganisms from un- or underexplored niches (<xref ref-type="bibr" rid="B24">Jiang et&#x20;al., 2018</xref>; <xref ref-type="bibr" rid="B23">Jiang et&#x20;al., 2021a</xref>). In this study, we report that these accumulating efforts have resulted in the isolation of multiple endophytes from <italic>S. acutum</italic>, and bioactivity-guided natural product isolation have yielded eight compounds, including a new dibenzo-&#x3b1;-pyrone derivative, ellagic acid B (<bold>5</bold>) and four new &#x3b1;-pyrone diaporpyrone A&#x2013;D (<bold>9</bold>&#x2013;<bold>12</bold>), together with three known compounds (<bold>6</bold>&#x2013;<bold>8</bold>). Further biological evaluation of these compounds revealed that 2-hydroxy-alternariol (<bold>6</bold>) and alternariol (<bold>7</bold>) are potential iNOS inhibitors.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>General Methods</title>
<p>The instruments (including those applied for optical rotations, MS, ORD, NMR, and ECD) and routine reagents for chemical isolation and biological evaluation were the same as those reported previously (<xref ref-type="bibr" rid="B23">Jiang et&#x20;al., 2021a</xref>). The details were listed in the Supporting Information.</p>
</sec>
<sec id="s2-2">
<title>Isolation of Endophytes and Fermentation</title>
<p>The separation methods of endophytic fungi are detailed in the Supporting Information. These endophytic fungi CB10098-CB10104 were isolated from the stems and roots of <italic>S. acutum</italic>, which were collected from Huaihua (Hunan, China) in October 2017. They were grown in PDA (0.3% potato extract, 2% glucose, 1.5% agar power) medium at 28&#xb0;C for 5&#xa0;day, and then inoculated to seed medium [glucose 2%, sucrose 1%, soybean powder 0.2%, peptone 1%, K<sub>2</sub>HPO<sub>4</sub> 0.03%, poly (ethylene glycol) 0.25%, NaNO<sub>3</sub> 0.3%, and (NH<sub>4</sub>)<sub>2</sub>SO<sub>4</sub> 0.3%]. The final pH of the medium was adjusted to 6.0 before sterilization with an autoclave at 121&#xb0;C for 20&#xa0;min. Cultures were incubated in flasks at 28&#xb0;C on a rotary shaker at 220&#xa0;rpm for 3&#xa0;day to prepare the seed culture. Next, they were transferred to 2&#x20;&#xd7; 500&#xa0;ml Erlenmeyer flasks contained rice (50&#xa0;g) and H<sub>2</sub>O (50&#xa0;ml). After sterilization in an autoclave at 121&#xb0;C for 30&#x20;min, each flask was inoculated with 10&#xa0;ml of seed culture and incubated at 28&#xb0;C for 40&#xa0;day. Finally, the solid rice culture containing the respective fungus were extracted by ethyl acetate to obtain extracts C1&#x2013;C6.</p>
</sec>
<sec id="s2-3">
<title>Fungal Strain</title>
<p>The strain CB10100 was identified as <italic>Diaporthe</italic> sp. according to molecular identification and its ITS sequence has 99% sequence identity to that of <italic>Diapo</italic>
<italic>rthe</italic> sp. The sequence data have been deposited to GenBank with the accession number MW037206. The strain was deposited in the Xiangya International Academy of Translational Medicine, Central South University, Changsha, Hunan, China.</p>
</sec>
<sec id="s2-4">
<title>Large-Scale Fermentation of <italic>Diaporthe</italic> sp. CB10100</title>
<p>For large-scale fermentation of <italic>Diaporthe</italic> sp. CB10100, 185&#x20;&#xd7; 1&#xa0;L Erlenmeyer flasks containing rice (100&#xa0;g) and H<sub>2</sub>O (100&#xa0;ml) were used. The fermented solid rice culture was supersonically extracted with EtOAc (3 &#xd7; 60&#xa0;L), and after recovering the organic solvent, the crude extract was suspended in water and successively treated with petroleum ether, ethyl acetate, and n-butanol.</p>
</sec>
<sec id="s2-5">
<title>Isolation of Compounds 5&#x2013;12</title>
<p>The EtOAc-soluble fraction (192.8&#xa0;g) was subjected to silica gel column chromatography using petroleum/EtOAc (v/v, 20:1 &#x2192; 10:1 &#x2192; 5:1 &#x2192; 1:1 &#x2192; 1:5 &#x2192; 1:20), EtOAc, EtOAc/MeOH (v/v 1:0 &#x2192; 1:5 &#x2192; 0:1)to yield nine combined fractions (Fr. A to J). Fr. B (27.13&#xa0;g) was chromatographed on ODS column (MeOH/H<sub>2</sub>O v/v 3:7 &#x2192; 4:6 &#x2192; 5:5 &#x2192; 6:4 &#x2192; 7:3) to yield six combined fractions (Fr. A1 to A6). Fr. A3 was separated by Sephadex LH-20 by employing MeOH/CH<sub>2</sub>Cl<sub>2</sub> (7:3, v/v) as mobile phase, followed by purification using semi-preparative HPLC with isocratic MeCN/H<sub>2</sub>O [containing 0.2% formic acid, MeCN/H<sub>2</sub>O, v/v, 10: 90&#x20;&#x2192; 70:30 (0&#x2013;11&#xa0;min); 70:30 (11&#x2013;12&#xa0;min); 70:30 &#x2192; 10:90 (12&#x2013;20&#xa0;min); 10:90 (20&#x2013;21&#xa0;min)] as mobile phase to yield <bold>6</bold> (10.6&#xa0;mg), <bold>7</bold> (30.6&#xa0;mg), along with known <bold>8</bold> (5.3&#xa0;mg). Following the same procedure, <bold>5</bold> (4.6&#xa0;mg) was obtained from Fr.&#x20;A5.</p>
<p>The petroleum ether fraction (447.6&#xa0;g) was subjected to silica gel column chromatography using a step gradient elution of petroleum/EtOAc (v/v, 20:1 &#x2192; 5:1 &#x2192; 1:1 &#x2192; 1:10), EtOAc, EtOAc/MeOH (v/v 1:0 &#x2192; 10:1 &#x2192; 1:1 &#x2192; 0:1) to yield ten combined fractions (Fr. 2A to 2H). Fr. 2&#xa0;J (57.86&#xa0;g) was chromatographed on ODS column (MeOH: H<sub>2</sub>O v/v 3:7 &#x2192; 4:6 &#x2192; 5:5 &#x2192; 6:4 &#x2192; 7:3) to yield ten combined fractions (Fr. 2J-1 to 2J-10). Fr. 2J-2 (1.32&#xa0;g) was chromatographed on ODS column (MeOH/H<sub>2</sub>O v/v 3:7 &#x2192; 4:6 &#x2192; 5:5 &#x2192; 6:4 &#x2192; 7:3), Sephadex LH-20 (MeOH) column and repeated purification by semipreparative HPLC [containing 0.2% formic acid, MeCN/H<sub>2</sub>O, v/v, 5: 95&#x20;&#x2192; 25:75 (0&#x2013;11&#xa0;min); 25:75 (11&#x2013;12&#xa0;min); 25:75 &#x2192; 5:95 (12&#x2013;20&#xa0;min); 5:95 (20&#x2013;21&#xa0;min)], which resulted in <bold>9</bold> (4.3&#xa0;mg) and <bold>10</bold> (5.6&#xa0;mg). In the same manner, <bold>11</bold> (2.7&#xa0;mg) and <bold>12</bold> (1.0&#xa0;mg) were obtained from Fr. 2J -&#x20;1.</p>
<sec id="s2-5-1">
<title>Ellagic acid B (<bold>5</bold>)</title>
<p>Dark-grey powder; UV (MeOH) &#x3bb;max 200.9, 255.2, 287.2, 363.7 (see <xref ref-type="sec" rid="s9">Supplementary Figure S4A</xref>); <sup>1</sup>H, <sup>13</sup>C and 2D NMR spectroscopic data, see <xref ref-type="table" rid="T1">Table&#x20;1</xref> and <xref ref-type="sec" rid="s9">Supplementary Figures S7&#x2013;S13</xref>; HRESIMS <italic>m/z</italic> 287.0197 [M - H]<sup>&#x2212;</sup> (calcd for C<sub>14</sub>H<sub>7</sub>O<sub>7</sub>, 287.0197).</p>
<table-wrap id="T1" position="float">
<label>TABLE 1</label>
<caption>
<p>
<sup>1</sup>H NMR (500&#xa0;MHz) and <sup>13</sup>C NMR (125&#xa0;MHz) data of <bold>5</bold> and <bold>6</bold> in DMSO-<italic>d</italic>
<sub>6</sub>.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Position</th>
<th colspan="2" align="center">
<bold>5</bold>
</th>
<th colspan="2" align="center">
<bold>6</bold>
</th>
</tr>
<tr>
<th align="center">&#x3b4;<sub>C,</sub> type</th>
<th align="center">&#x3b4;<sub>H</sub>, mult. (J in Hz)</th>
<th align="center">&#x3b4;<sub>C</sub>, type</th>
<th align="center">&#x3b4;<sub>H</sub>, mult. (J in Hz)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">1</td>
<td align="center">120.4, C</td>
<td align="left"/>
<td align="center">122.0, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">2</td>
<td align="center">101.5, CH</td>
<td align="center">6.69, s</td>
<td align="center">141.7, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">3</td>
<td align="center">149.4, C</td>
<td align="left"/>
<td align="center">147.7, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">4</td>
<td align="center">142.1, C</td>
<td align="left"/>
<td align="center">101.0, CH</td>
<td align="center">6.7, s</td>
</tr>
<tr>
<td align="left">4a</td>
<td align="center">102.8, C</td>
<td align="left"/>
<td align="center">144.9, C<xref ref-type="table-fn" rid="Tfn1">
<sup>&#x002A;</sup>
</xref>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">4b</td>
<td align="center">138.2, C</td>
<td align="left"/>
<td align="center">109.2, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">6</td>
<td align="center">163.9, C</td>
<td align="left"/>
<td align="center">165.2, C<xref ref-type="table-fn" rid="Tfn1">
<sup>&#x002A;</sup>
</xref>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">6a</td>
<td align="center">129.8, C</td>
<td align="left"/>
<td align="center">97.8, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">6b</td>
<td align="center">94.1, C</td>
<td align="left"/>
<td align="center">138.7, C<xref ref-type="table-fn" rid="Tfn1">
<sup>&#x002A;</sup>
</xref>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">7</td>
<td align="center">102.4, CH</td>
<td align="center">6.31, s</td>
<td align="center">164.1, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">7-OH</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="center">11.87, s</td>
</tr>
<tr>
<td align="left">8</td>
<td align="center">154.2, C</td>
<td align="left"/>
<td align="center">100.8, C</td>
<td align="center">6.34, br s</td>
</tr>
<tr>
<td align="left">9</td>
<td align="center">156.5, C</td>
<td align="left"/>
<td align="center">165.0, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">9a</td>
<td align="center">114.4, C</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">10</td>
<td align="left"/>
<td align="left"/>
<td align="center">104.4, CH</td>
<td align="center">7.26, br s</td>
</tr>
<tr>
<td align="left">11</td>
<td align="center">63.3, CH<sub>2</sub>
</td>
<td align="center">5.30, s</td>
<td align="center">16.0, CH<sub>3</sub>
</td>
<td align="center">2.58, s</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn1">
<label>&#x002A;</label>
<p>Not detected (<xref ref-type="bibr" rid="B6">Chapla et&#x20;al., 2014</xref>).</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2-5-2">
<title>Diaporpyrone A (9)</title>
<p>White powder; UV (MeOH) &#x3bb;max 202.1, 220.9, 308.7 (see <xref ref-type="sec" rid="s9">Supplementary Figure S4E</xref>); <sup>1</sup>H, <sup>13</sup>C and 2D NMR spectroscopic data, see <xref ref-type="table" rid="T2">Table&#x20;2</xref>; <xref ref-type="sec" rid="s9">Supplementary Figures S35&#x2013;S48</xref>; HRESIMS <italic>m/z</italic> 195.0655 [M - H]<sup>&#x2212;</sup> (calcd for C<sub>10</sub>H<sub>11</sub>O<sub>4</sub>,195.0663).</p>
<table-wrap id="T2" position="float">
<label>TABLE 2</label>
<caption>
<p>
<sup>1</sup>H NMR (<sup>a</sup>500&#xa0;MHz) or (<sup>b</sup>400&#xa0;MHz) and <sup>13</sup>C NMR (<sup>a</sup>125&#xa0;MHz) or (<sup>b</sup>100&#xa0;MHz) data of <bold>9&#x2013;12</bold> in CD<sub>3</sub>OD.</p>
</caption>
<table>
<thead valign="top">
<tr>
<th rowspan="2" align="center">Position</th>
<th colspan="2" align="center">9<sup>b</sup>
</th>
<th colspan="2" align="center">10<sup>a</sup>
</th>
<th colspan="2" align="center">11<sup>b</sup>
</th>
<th colspan="2" align="center">12<sup>a</sup>
</th>
</tr>
<tr>
<th align="center">&#x3b4;<sub>C</sub>, type</th>
<th align="center">&#x3b4;<sub>H</sub>, mult. (J in Hz)</th>
<th align="center">&#x3b4;<sub>C</sub>, type</th>
<th align="center">&#x3b4;<sub>H</sub>, mult. (J in Hz)</th>
<th align="center">&#x3b4;<sub>C</sub>, type</th>
<th align="center">&#x3b4;<sub>H</sub>, mult. (J in Hz)</th>
<th align="center">&#x3b4;<sub>C</sub>, type</th>
<th align="center">&#x3b4;<sub>H</sub>, mult. (J in Hz)</th>
</tr>
</thead>
<tbody valign="top">
<tr>
<td align="left">2</td>
<td align="center">165.2, C</td>
<td align="left"/>
<td align="center">164.8, C</td>
<td align="left"/>
<td align="center">165.3, C</td>
<td align="left"/>
<td align="center">165.2, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">3</td>
<td align="center">113.7, CH</td>
<td align="center">6.17, d (9.6)</td>
<td align="center">114.1, CH</td>
<td align="center">6.23, d (9.5)</td>
<td align="center">113.7, CH</td>
<td align="center">6.20, d (9.6)</td>
<td align="center">112.8, CH</td>
<td align="center">6.18, d (9.5)</td>
</tr>
<tr>
<td align="left">4</td>
<td align="center">149.6, CH</td>
<td align="center">7.44, d (9.6)</td>
<td align="center">145.9, CH</td>
<td align="center">7.62, d (9.5)</td>
<td align="center">149.7, CH</td>
<td align="center">7.48, d (9.6)</td>
<td align="center">150.2, CH</td>
<td align="center">7.45, d (9.5)</td>
</tr>
<tr>
<td align="left">5</td>
<td align="center">116.9, C</td>
<td align="left"/>
<td align="center">120.6, C</td>
<td align="left"/>
<td align="center">116.8, C</td>
<td align="left"/>
<td align="center">113.2, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">6</td>
<td align="center">160.4, C</td>
<td align="left"/>
<td align="center">160.0, C</td>
<td align="left"/>
<td align="center">160.6, C</td>
<td align="left"/>
<td align="center">161.7, C</td>
<td align="left"/>
</tr>
<tr>
<td align="left">1'</td>
<td align="center">29.5, CH<sub>2</sub>
</td>
<td align="center">2.41, t (7.2)</td>
<td align="center">68.6, CH</td>
<td align="center">4.61, t (7.0)</td>
<td align="center">70.9, CH</td>
<td align="center">4.08, m</td>
<td align="center">35.4, CH<sub>2</sub>
<xref ref-type="table-fn" rid="Tfn2">
<sup>&#x002A;</sup>
</xref>
</td>
<td align="center">3.36, s</td>
</tr>
<tr>
<td align="left">2'</td>
<td align="center">26.2, CH<sub>2</sub>
</td>
<td align="center">1.79, m</td>
<td align="center">37.7, CH<sub>2</sub>
</td>
<td align="center">1.76, m 1.57, m</td>
<td align="center">35.2, CH<sub>2</sub>
</td>
<td align="center">1.96, m 1.86, m</td>
<td align="center">175.7, C<xref ref-type="table-fn" rid="Tfn2">
<sup>&#x002A;</sup>
</xref>
</td>
<td align="left"/>
</tr>
<tr>
<td align="left">3'</td>
<td align="center">34.4, CH<sub>2</sub>
</td>
<td align="center">2.33, t (7.2)</td>
<td align="center">26.2, CH<sub>2</sub>
</td>
<td align="center">1.36, m</td>
<td align="center">25.9, CH<sub>2</sub>
</td>
<td align="center">2.52, m</td>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">4'</td>
<td align="center">176.8, C</td>
<td align="left"/>
<td align="center">26.0, CH<sub>2</sub>
</td>
<td align="center">1.63, m</td>
<td align="center">176.7, C</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">5'</td>
<td align="left"/>
<td align="left"/>
<td align="center">35.2, CH<sub>2</sub>
</td>
<td align="center">2.29, t (4.5)</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">6'</td>
<td align="left"/>
<td align="left"/>
<td align="center">178.1, C</td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left">1''</td>
<td align="center">17.2, CH<sub>3</sub>
</td>
<td align="center">2.27, s</td>
<td align="center">17.0, CH<sub>3</sub>
</td>
<td align="center">2.27, s</td>
<td align="center">17.2, CH<sub>3</sub>
</td>
<td align="center">2.32, s</td>
<td align="center">17.6, CH<sub>3</sub>
</td>
<td align="center">2.26, s</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="Tfn2">
<label>&#x002A;</label>
<p>Not detected.</p>
</fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="s2-5-3">
<title>Diaporpyrone B (10)</title>
<p>White powder; UV (MeOH) &#x3bb;max 196.2, 301.5 (see <xref ref-type="sec" rid="s9">Supplementary Figure S4F</xref>) [&#x3b1;] <sup>23.6</sup>
<sub>D</sub> &#x2b;1.92 (c 0.12, MeOH); ECD (MeOH) &#x3bb; (&#x3b5;) 303 (&#x2212;1.22), 233 (2.02), 208(&#x2212;5.97); <sup>1</sup>H, <sup>13</sup>C and 2D NMR spectroscopic data, see <xref ref-type="table" rid="T2">Table&#x20;2</xref>; <xref ref-type="sec" rid="s9">Supplementary Figures S49&#x2013;S56</xref>; HRESIMS <italic>m/z</italic> 239.0922 [M - H]<sup>-</sup> (calcd for C<sub>12</sub>H<sub>15</sub>O<sub>5</sub>, 239.0925).</p>
</sec>
<sec id="s2-5-4">
<title>Diaporpyrone C (11)</title>
<p>White powder; UV (MeOH) &#x3bb;max 197.4, 223.3, 307.5 (see <xref ref-type="sec" rid="s9">Supplementary Figure S4G</xref>) [&#x3b1;] <sup>23.6</sup>
<sub>D</sub> 170&#x2b;14.72 (c 0.072, MeOH); <sup>1</sup>H, <sup>13</sup>C and 2D NMR spectroscopic data, see <xref ref-type="table" rid="T2">Table&#x20;2</xref>; <xref ref-type="sec" rid="s9">Supplementary Figures S57&#x2013;S64</xref>; HRESIMS <italic>m/z</italic> 211.0607 [M&#x20;- H]<sup>&#x2212;</sup> (calcd for C<sub>10</sub>H<sub>11</sub>O<sub>5</sub>, 211.0612).</p>
</sec>
<sec id="s2-5-5">
<title>Diaporpyrone D (12)</title>
<p>White powder; UV (MeOH) &#x3bb;max 199.7, 220.9, 303.9 (see <xref ref-type="sec" rid="s9">Supplementary Figure S4H</xref>); <sup>1</sup>H, <sup>13</sup>C and 2D NMR spectroscopic data, see <xref ref-type="table" rid="T2">Table&#x20;2</xref>; <xref ref-type="sec" rid="s9">Supplementary Figures S65&#x2013;S71</xref>; HRESIMS <italic>m/z</italic> 167.0340 [M - H]<sup>&#x2212;</sup> (calcd for C<sub>8</sub>H<sub>7</sub>O<sub>4</sub>, 167.0350).</p>
</sec>
</sec>
<sec id="s2-6">
<title>ECD Calculation Methods</title>
<p>The ECD spectrum of diaporpyrone B <bold>(10)</bold> was calculated by using of the Gaussian 09 package (<xref ref-type="bibr" rid="B14">Frisch et&#x20;al., 2010</xref>). Those configurations were optimized at the B3LYP/6-31G (d) level. The ECD spectrum were calculated by the TDDFT method at the B3LYP/6&#x2013;311&#x2b; &#x2b;G (2&#xa0;day, <italic>p</italic>) level with the CPCM model in methanol solution (<xref ref-type="bibr" rid="B4">Bruhn et&#x20;al., 2013</xref>). The details were listed in the Supporting Information.</p>
</sec>
<sec id="s2-7">
<title>Cell Culture and Cell Viability Assay</title>
<p>Cell culture and cell viability assay (<xref ref-type="bibr" rid="B32">Liu et&#x20;al., 2016</xref>) was utilized to investigate the maximum concentration of every compound that was not toxic to cells. The method for cell culture and cell viability assay was in the <xref ref-type="sec" rid="s9">Supplementary Material</xref>.</p>
</sec>
<sec id="s2-8">
<title>Western Blotting for the Detection of iNOS and COX-2</title>
<p>The iNOS and COX-2 protein levels affected by compounds <bold>5</bold>&#x2013;<bold>12</bold> were detected using Western blotting according to the reported procedures, and dexamethasone was used as the positive control (<xref ref-type="bibr" rid="B23">Jiang et&#x20;al., 2021a</xref>). The procedure is detailed in the <xref ref-type="sec" rid="s9">Supplementary Material</xref>.</p>
</sec>
<sec id="s2-9">
<title>Detection of NO and Inflammatory Cytokines Production</title>
<p>RAW264.7 cells were seeded in 12-well plates in a density of 2&#x20;&#xd7; 10<sup>5</sup> cells/mL and incubated for 24&#xa0;h. Three different concentration compounds were added in the each well for 1&#xa0;h before LPS stimulation. The culture medium was collected and stored at &#x2212;80&#xb0;C. The levels of nitric oxide in the culture medium were detected using the Nitric oxide detection kit (Invitrogen) and the levels of TNF-&#x3b1;, IL-6 and MCP-1 were analyzed using the ELISA kits (eBioscience).</p>
</sec>
<sec id="s2-10">
<title>Molecular Docking Analysis</title>
<p>Molecular docking studies were conducted by the software Molecular Operating Environment (MOE 2010.06; Chemical Computing Group, Canada) as the computational platform. The procedure is detailed in the <xref ref-type="sec" rid="s9">Supplementary Material</xref>.</p>
</sec>
<sec id="s2-11">
<title>Statistical Analysis</title>
<p>The results are expressed as mean&#x20;&#xb1; SD of at least three independent experiments. Statistical significance of differences between groups was determined by ANOVA, and a level of &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05 or &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01 was considered statistically significant.</p>
</sec>
</sec>
<sec sec-type="results|discussion" id="s3">
<title>Results and Discussion</title>
<sec id="s3-1">
<title>Isolation of Endophylic Fungi From <italic>Sinomenium acutum</italic>
</title>
<p>Six endophytic fungi CB10098-CB10104 were isolated from the stems and roots of <italic>S. acutum</italic>, collected in Huaihua city in central China (<xref ref-type="sec" rid="s9">Supplementary Figure S1</xref>). These endophytic microorganisms were fermented and the anti-inflammatory activity of their crude extracts C1&#x2013;C6 was evaluated in a lipopolysaccharide (LPS)-stimulated RAW264.7 cells. Several crude extracts, e.g., C3 (from CB10100) and C5 (from CB10102), showed the specific inhibition against iNOS at a concentration of 20&#xa0;&#x3bc;g/ml (<xref ref-type="sec" rid="s9">Supplementary Figure S1C</xref>). Next, the fungus CB10100 was identified as a <italic>Diaporthe</italic> species based on DNA sequencing of its internal transcribed spacer 4 (ITS4) and the phylogenetic analysis of its ITS4 with selected <italic>Diaporthe</italic> strains in GenBank (<xref ref-type="sec" rid="s9">Supplementary Figure S2</xref>). <italic>Diaporthe,</italic> the sexual morph of <italic>Phomopsis</italic> and a known plant pathogen (<xref ref-type="bibr" rid="B21">Huang et&#x20;al., 2013</xref>), lives in a diversity of plants (<xref ref-type="bibr" rid="B16">Guarnaccia and Crous, 2017</xref>). Some <italic>Diaporthe</italic> or <italic>Phomopsis</italic> species can also produce bioactive small molecules and protect host plants from fungi infection (<xref ref-type="bibr" rid="B41">Tan and Zou, 2001</xref>). For example, several bioactive metabolites were discovered, including anthraquinones (<italic>i.e.,</italic> cytoskyrin A), terpenes (<italic>i.e.,</italic> diaporthein A), alkaloids (<italic>i.e.,</italic> diaporisoindoles A) (<xref ref-type="bibr" rid="B8">Chepkirui and Stadler, 2017</xref>) (<xref ref-type="sec" rid="s9">Supplementary Figure S3</xref>). Therefore, a scale-up solid fermentation of <italic>Diaporthe</italic> sp. CB10100 (185 &#xd7; 1&#xa0;L flasks containing 100&#xa0;g boiled rice) was next used to isolate natural products with anti-inflammatory activity.</p>
</sec>
<sec id="s3-2">
<title>Structure Elucidation</title>
<p>The obtained <italic>Diaporthe</italic> sp. CB10100 crude extract was further fractioned based on silico gel and Sephadex LH-20 chromatography and semi-preparative HPLC, which yielded compounds <bold>5&#x2013;12</bold>. Alternariol (<bold>7</bold>) and alternariol-9-monomethyl ether (<bold>8</bold>) are known compounds, and their structures were established based on the comparison of their 1D and 2D NMR spectra, HRMS, and UV spectra with the literature (<xref ref-type="sec" rid="s9">Supplementary Figures S4C,D, S6C,D, S21&#x2013;S34</xref>) (<xref ref-type="bibr" rid="B18">Hildebrand et&#x20;al., 2015</xref>). Although 2-hydroxy- alternariol <bold>(6)</bold> was reported in 2007 and 2014 (<xref ref-type="bibr" rid="B35">Pfeiffer et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B6">Chapla et&#x20;al., 2014</xref>), three carbons signals of <bold>6</bold> were not identified. Therefore, a complete set of NMR assignment of <bold>6</bold> is listed in <xref ref-type="table" rid="T1">Table&#x20;1</xref>, based on our full set of NMR spectra (<xref ref-type="sec" rid="s9">Supplementary Figures S14&#x2013;S20</xref>).</p>
<p>Ellagic acid B <bold>(5)</bold> was isolated as colorless powder. Its molecular formula is established as C<sub>14</sub>H<sub>8</sub>O<sub>7</sub> based on the (-) -HRESIMS analysis at <italic>m/z</italic> 287.0197 [M - H]<sup>&#x2212;</sup> (calcd for C<sub>14</sub>H<sub>7</sub>O<sub>7</sub>, 287.0197), suggesting 11 degrees of unsaturation. Its <sup>13</sup>C NMR spectrum (<xref ref-type="table" rid="T1">Table&#x20;1</xref>) shows a total of 14 signals that could be classified as an ester carbonyl (<italic>&#x3b4;</italic>
<sub>C</sub>, 163.9), 12 sp<sup>2</sup>-hybridized carbons (including two methine and six quaternary carbons), and one oxygenated aliphatic carbon (<italic>&#x3b4;</italic>
<sub>C</sub> 63.3), assisted by DEPT-135 and HSQC spectra (<xref ref-type="sec" rid="s9">Supplementary Figures S10, S11</xref>). The presence of two aromatic singlet protons at <italic>&#x3b4;</italic>
<sub>H</sub> 6.31 (s) and 6.69 (s) suggests the presence of a likely biphenyl structure. Based on these analyses and the similar UV spectra with <bold>6</bold>&#x2013;<bold>8</bold>, compound <bold>5</bold> may contain a new dibenzo-&#x3b1;-pyrone ring system with an additional fused &#x3b1;-pyran moiety. This was corroborated by its HMBC spectrum, showing correlations from the aromatic proton H-2 (<italic>&#x3b4;</italic>
<sub>H</sub> 6.69, s) to C-1, C-3, C-4, C-4b, and from H-7 (<italic>&#x3b4;</italic>
<sub>H</sub> 6.31, s) to C-6, C-6a, C-6b, C-8, and C-9, as well as from one methylene (<italic>&#x3b4;</italic>
<sub>H</sub> 5.29, s) to C-1, C-2, C-4b, C-9a (<xref ref-type="fig" rid="F2">Figure&#x20;2</xref>). To our knowledge, this represents a new tetracyclic 6/6/6/6 ring system derived from dibenzo-&#x3b1;-pyrones.</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>
<bold>(A)</bold> Key <sup>1</sup>H&#x2013;<sup>1</sup>H COSY and HMBC correlations of compounds <bold>5</bold> and <bold>9&#x2013;12</bold>. <bold>(B)</bold> Experimental and calculated ECD spectra of compounds <bold>10</bold> in MeOH.</p>
</caption>
<graphic xlink:href="fchem-09-679592-g002.tif"/>
</fig>
<p>Diaporpyrone A <bold>(9)</bold> was isolated as a colorless powder. Its molecular formula was determined as C<sub>10</sub>H<sub>12</sub>O<sub>4</sub> on the basis of HRESIMS analysis, affording an [M - H]<sup>&#x2212;</sup> ion at <italic>m/z</italic> 195.0655 [M&#x20;- H]<sup>&#x2212;</sup> (calculated for [M - H]<sup>&#x2212;</sup> ion at <italic>m/z</italic> 195.0663). The <sup>1</sup>H and <sup>13</sup>C NMR data of <bold>9</bold> are similar to a previously isolated pyrone with a six-carbon aliphatic chain from an endophytic fungus <italic>Pericinia</italic> sp. F-31, with the replacement of the terminal methyl group by a carboxylic acid (<italic>&#x3b4;</italic>
<sub>C</sub> 178.1) (<xref ref-type="table" rid="T2">Table&#x20;2</xref>; <xref ref-type="sec" rid="s9">Supplementary Figure S36</xref>; <xref ref-type="bibr" rid="B45">Zhang et&#x20;al., 2015</xref>). This was confirmed by the HMBC correlations from 1&#x2033; -CH<sub>3</sub> to C-5 (<italic>&#x3b4;</italic>
<sub>C</sub> 116.9) and C-6 (<italic>&#x3b4;</italic>
<sub>C</sub> 160.4), and from C-3 <sup>&#x2b9;</sup> (<italic>&#x3b4;</italic>
<sub>C</sub> 34.4) to C-4 <sup>&#x2b9;</sup> (<italic>&#x3b4;</italic>
<sub>C</sub> 176.8) and C-2<sup>&#x2b9;</sup> (<italic>&#x3b4;</italic>
<sub>C</sub> 26.2). We named the new &#x3b1;-pyrone <bold>9</bold> as diaporpyrone A, since it is from the fungus <italic>Diaporthe</italic> sp. CB10100.</p>
<p>Diaporpyrone B <bold>(10)</bold> was isolated as colorless powder. Its molecular formula was established as C<sub>12</sub>H<sub>16</sub>O<sub>5</sub> based on the (-)-HRESIMS analysis at m/z 239.0922 [M - H]<sup>&#x2212;</sup> (calcd for C<sub>12</sub>H<sub>15</sub>O<sub>5</sub>, 239.0925). The <sup>13</sup>C NMR and DEPT spectra of 10 shows a total of 12 signals containing two carbonyl carbon (<italic>&#x3b4;</italic>
<sub>C</sub> 178.1 and 164.8), two nonprotonated carbons (<italic>&#x3b4;</italic>
<sub>C</sub> 160.0, 120.6), two olefinic methine carbon (<italic>&#x3b4;</italic>
<sub>C</sub> 145.9, 114.1), an oxymethine carbons (<italic>&#x3b4;</italic>
<sub>C</sub> 68.6), four methylene carbons (<italic>&#x3b4;</italic>
<sub>C</sub> 37.7, 35.2, 26.2, and 26.0), and one methyl carbon (<italic>&#x3b4;</italic>
<sub>C</sub> 17.0) (<xref ref-type="table" rid="T2">Table&#x20;2</xref>). The UV spectra of <bold>10</bold> resembled that of <bold>9</bold>, and most of the <sup>1</sup>H and <sup>13</sup>C NMR data of <bold>10</bold> are similar to those of <bold>9</bold>. In the <sup>1</sup>H NMR, <sup>13</sup>C NMR, and HSQC spectra of <bold>10</bold>, additional signals attributed to the presence of a hydroxy group on C-1&#x2032; (<italic>&#x3b4;</italic>
<sub>C</sub> 68.6). This was confirmed by the HMBC correlations from C-1&#x2032; to C-4 (<italic>&#x3b4;</italic>
<sub>C</sub> 145.9), C-5 (<italic>&#x3b4;</italic>
<sub>C</sub> 120.6), C-6 (<italic>&#x3b4;</italic>
<sub>C</sub> 160.0), and the correlations of H-1&#x2032;/H<sub>2</sub>-2&#x2032;/H<sub>2</sub>-3&#x2032;/H<sub>2</sub>-4&#x2032;/H<sub>2</sub>-5&#x2032; in the COSY spectrum of <bold>10</bold> (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>). Electronic circular dichroism (ECD) calculations were next employed to determine the absolute configuration of <bold>10</bold> by comparing the ECD spectra of (1&#x2b9;<italic>S</italic>)<bold>-10</bold> and (1&#x2b9;<italic>R</italic>)<bold>-10</bold> with the experimental result, which suggests that a (1&#x2b9;<italic>R</italic>)<bold>-10</bold> configuration (<xref ref-type="fig" rid="F2">Figure&#x20;2B</xref>; <xref ref-type="bibr" rid="B4">Bruhn et&#x20;al., 2013</xref>). In addition, the specific rotation value [&#x3b1;]<sup>23.6</sup>
<sub>D</sub> &#x2b;1.92 (c 0.12, MeOH) was in opposite with the published specific rotation value of similar &#x3b1;-pyrones dothideopyrone A ([&#x3b1;]<sup>25</sup>
<sub>D</sub> -77 (c 0.22, CHCl<sub>3</sub>)) (<xref ref-type="bibr" rid="B9">Chomcheon et&#x20;al., 2009</xref>) and dothideopyrone F ([&#x3b1;]<sup>25</sup>
<sub>D</sub> -118.72 (c 0.05, MeOH)) (<xref ref-type="bibr" rid="B26">Kim et&#x20;al., 2018</xref>), with an <italic>S</italic>-configuration at C-1&#x2032;.</p>
<p>Diaporpyrone C <bold>(11)</bold> was isolated as colorless powder, and its molecular formula was determined as C<sub>10</sub>H<sub>12</sub>O<sub>5</sub> by the (-)-HRESIMS <italic>m/z</italic> 211.0607 [M - H]<sup>&#x2212;</sup> (calcd for C<sub>10</sub>H<sub>11</sub>O<sub>5</sub>, 211.0612), differing from the molecular formula of <bold>10</bold> by two methylenes. The UV spectrum and 1D and 2D NMR data of <bold>11</bold> are similar to those of <bold>10</bold> (<xref ref-type="sec" rid="s9">Supplementary Figures S4F,G</xref>; <xref ref-type="table" rid="T2">Table&#x20;2</xref>), suggesting that <bold>10</bold> and <bold>11</bold> are similar &#x3b1;-pyrones with a fatty acid side chain. The complete structure of <bold>11</bold> was fully assigned based on <sup>1</sup>H&#x2212;<sup>1</sup>H COSY, HSQC, and HMBC data (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>; <xref ref-type="table" rid="T2">Table&#x20;2</xref>). Since diaporpyrones B <bold>(10)</bold> and C <bold>(11)</bold> likely share the same biosynthetic route, diaporpyrone C <bold>(11)</bold> may have the same absolute configuration at C-1&#x2032; position, which is further supported by its specific rotation value [&#x3b1;]<sup>23.6</sup>
<sub>D</sub> &#x2b;14.72 (c 0.072, MeOH), similar to that of diaporpyrone B&#x20;<bold>(10)</bold>.</p>
<p>Diaporpyrone D <bold>(12)</bold> was isolated as colorless powder, and its molecular formula was determined as C<sub>8</sub>H<sub>8</sub>O<sub>4</sub> by the (-)-HRESIMS <italic>m/z</italic> 167.0340 [M - H]<sup>&#x2212;</sup> (calcd for C<sub>8</sub>H<sub>7</sub>O<sub>4</sub>, 167.0350), differing from the molecular formula of <bold>9</bold> by two methylenes. The UV maximum absorption and 1D NMR data were highly similar to those of <bold>9</bold> (<xref ref-type="table" rid="T2">Table&#x20;2</xref>; <xref ref-type="sec" rid="s9">Supplementary Figures S4E,H</xref>), suggesting the presence of a similar carbon skeleton. The signals for 35.4 and 175.7&#xa0;ppm are not present in the <sup>13</sup>C NMR spectrum of <bold>12</bold>, while they are present in both HSQC and HMBC spectra (<xref ref-type="sec" rid="s9">Supplementary Figures S69, S70</xref>). The complete structure of <bold>12</bold> was fully assigned based on these data. The complete structure of <bold>12</bold> was fully assigned based on <sup>1</sup>H&#x2212;<sup>1</sup>H COSY, HSQC, and HMBC data (<xref ref-type="fig" rid="F2">Figure&#x20;2A</xref>; <xref ref-type="table" rid="T2">Table&#x20;2</xref>).</p>
</sec>
<sec id="s3-3">
<title>Biosynthetic Pathway Speculation for Compounds 5&#x2013;12</title>
<p>The biosynthesis of <bold>7</bold> and <bold>8</bold> was proposed in 2012, while their biosynthetic enzyme SnPKS19 was identified from a wheat pathogen <italic>Parastagonospora nodorum</italic> (<xref ref-type="bibr" rid="B27">Kim et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B10">Chooi et&#x20;al., 2015</xref>). Therefore, the biosynthesis of dibenzo-&#x03B1;-pyrone <bold>5</bold>&#x2013;<bold>8</bold> in <italic>Diaporthe</italic> sp. CB10100 may follow the similar biosynthetic logic, which involves the condensation of seven molecules of malonyl-CoA, followed by aldol-type cyclization between C-2 and C-7, and C-8 and C-13, and the subsequent lactonization leads to the key intermediate <bold>7</bold> (<xref ref-type="fig" rid="F3">Figure&#x20;3A</xref>). Subsequent methylation of the C-5 hydroxyl group of <bold>7</bold> by a methyltransferase would lead to <bold>8</bold>, and hydroxylation of C-2 of <bold>7</bold> may produce <bold>6</bold>. Further multi-step modifications of <bold>7</bold> may be envisioned to generate the unique conjugated four ring system of <bold>5</bold>, despite an alternative precursor of <bold>5</bold> may also be possible.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>Proposed biosynthetic pathways of <bold>5</bold>&#x2013;<bold>8</bold> <bold>(A)</bold> and <bold>9</bold>&#x2013;<bold>12</bold> <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fchem-09-679592-g003.tif"/>
</fig>
<p>The biosynthesis of pyrone <bold>9&#x2013;12</bold> may involve the condensation of three molecules of malonyl-CoA, followed by aldol-type cyclization and the subsequent lactonization to generate the key six-membered lactone intermediate by a PKS (<xref ref-type="fig" rid="F3">Figure&#x20;3B</xref>). Next, the additional fatty acid side chains with various lengths may be biosynthesized by a PKS and finally attached to the lactone to generate <bold>9&#x2013;12</bold>. The detailed biosynthetic mechanism of <bold>9&#x2013;12</bold> remains to be elucidated.</p>
</sec>
<sec id="s3-4">
<title>Effects of Compounds 5&#x2013;12 on LPS-Induced iNOS and COX-2 Expression in RAW264.7 Cells</title>
<p>iNOS and COX-2 are key proteins in the inflammatory signaling pathway. When inflammation occurs, iNOS and COX-2 are usually highly expressed, resulting the formation of inflammatory mediators, including NO and PGE<sub>2</sub> (<xref ref-type="bibr" rid="B29">Kyoung et&#x20;al., 2019</xref>). Many phenolic compounds exhibit anti-inflammatory activities through inhibition of the iNOS (<xref ref-type="bibr" rid="B28">Ku et&#x20;al., 2008</xref>; <xref ref-type="bibr" rid="B30">Laavola et&#x20;al., 2015</xref>). No anti-inflammatory activity of compound <bold>6</bold> was reported (<xref ref-type="bibr" rid="B35">Pfeiffer et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B6">Chapla et&#x20;al., 2014</xref>), while <bold>7</bold> was discovered to modify macrophage phenotype and to inhibit production of NO and inflammatory responses (<xref ref-type="bibr" rid="B40">Solhaug et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B7">Chen et&#x20;al., 2020</xref>). In addition, dothideopyrone F (<bold>2</bold>) was able to diminish the expression of iNOS and COX-2 in lipopolysaccharide (LPS)-induced BV2 cells (<xref ref-type="bibr" rid="B26">Kim et&#x20;al., 2018</xref>). Therefore, we hypothesize that the newly isolated natural products, e.g., <bold>5&#x2013;6</bold> and <bold>9&#x2013;12</bold>, may have certain anti-inflammatory activity. In lipopolysaccharide (LPS)-stimulated RAW264.7 cell model, we next evaluated their inhibitory activity of iNOS and COX-2 protein expression, along with <bold>7</bold> and <bold>8</bold>, using dexamethasone (DEX) as a positive control (<xref ref-type="fig" rid="F4">Figures 4A&#x2013;C</xref>).</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>Compounds <bold>6</bold> and <bold>7</bold> specifically inhibit iNOS. <bold>(A)</bold> Inhibitory effects of <bold>5</bold>&#x2013;<bold>12</bold> on LPS-induced iNOS and COX-2 protein expression in RAW264.7 cells. The cells were pretreated with <bold>5</bold>&#x2013;<bold>12</bold> (30&#xa0;&#x3bc;M) for 1&#xa0;h and then stimulated by LPS (100&#xa0;ng/ml) for 18&#xa0;h. <bold>(B and C)</bold> The protein levels of iNOS <bold>(B)</bold> and COX-2 <bold>(C)</bold> were quantitated using ChemiDoc<sup>TM</sup> XRS<sup>&#x2b;</sup> with image Lab<sup>TM</sup> software (Biorad) and the density ratio of iNOS or COX-2 to &#x3b2;-actin were shown. The density ratio of LPS only group was set to 1. <bold>(D and E)</bold> Effects of <bold>6</bold> and <bold>7</bold> with concentrations of 10, 20, and 40&#xa0;&#x3bc;M on the protein expression of iNOS. The results were the mean&#x20;&#xb1; SD, n &#x3d; 4. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01, vs. LPS alone. <bold>(F,G)</bold> The cytotoxicity of <bold>6</bold> and <bold>7</bold> on RAW264.7&#x20;cells.</p>
</caption>
<graphic xlink:href="fchem-09-679592-g004.tif"/>
</fig>
<p>Among the tested compounds, only <bold>6</bold> and <bold>7</bold> strongly inhibited iNOS protein expression, while they had no effects on COX-2 expression in a concentration of 30&#xa0;&#x3bc;M (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). To compare the anti-inflammatory activity of <bold>6</bold> and <bold>7</bold>, the anti-inflammatory activity of <bold>6</bold> and <bold>7</bold> in concentrations ranging from 10 to 40&#xa0;&#x3bc;M was determined in LPS-stimulated RAW264.7 cells. Both compounds inhibit the expression of iNOS in a dose-dependent manner (<xref ref-type="fig" rid="F4">Figures 4D,E</xref>). For example, <bold>6</bold> was able to inhibit about 90% of iNOS expression when applied at 20&#xa0;&#x3bc;M, while <bold>7</bold> showed slightly less inhibitory activity against iNOS expression. Therefore, the presence of multiple hydroxyl groups in the dibenzo-&#x03B1;-pyrone scaffold would be important for the observed inhibitory activity against iNOS expression, since the methylation of C-9 hydroxyl group abolishes the activity in <bold>8</bold>, while the additional C-2 hydroxyl group increases the activity of <bold>6</bold>. The fused &#x3b1;-pyran moiety into dibenzo-&#x03B1;-pyrone scaffold abolishes the inhibitory activity against iNOS expression activity in&#x20;<bold>5</bold>.</p>
<p>No significant cytotoxicity of both compounds to RAW264.7 cells was observed under the test conditions, even up to 100&#xa0;&#x3bc;M of <bold>6</bold> and <bold>7</bold> were used (<xref ref-type="fig" rid="F4">Figures 4F,G</xref>). Solhaug et&#x20;al. reported the cytotoxic activity of <bold>7</bold> in cells and we ascribe this difference as the shorter treatment period (18&#xa0;h) in our study, compared to the previously used 48&#xa0;h (<xref ref-type="bibr" rid="B40">Solhaug et&#x20;al., 2015</xref>). These results suggest that the inhibitory activities of <bold>6</bold> and <bold>7</bold> against iNOS expression in LPS-stimulated RAW264.7 cells did not involve general cytotoxicity.</p>
</sec>
<sec id="s3-5">
<title>2-Hydroxy-alternariol (6) and Alternariol (7) Decreased the Protein Levels of TNF-&#x3b1;, IL-6 and MCP-1 in LPS-Stimulated RAW264.7 Cells</title>
<p>Macrophages are central effectors in inflammation, and activated macrophages act through the release of cytokines, such as tumor necrosis factor &#x3b1; (TNF-&#x3b1;) and interleukin-6 (IL-6), as well as chemokines, such as monocyte chemoattractant protein-1 (MCP-1) (<xref ref-type="bibr" rid="B15">Fujiwara and Kobayashi, 2005</xref>). Since TNF-&#x3b1;, IL-6, and MCP-1 are major mediators of inflammation, we examined the effects of <bold>6</bold> and <bold>7</bold> on LPS-induced TNF-&#x3b1;, IL-6, and MCP-1 production in RAW264.7 cells, using DEX as a control (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;F</xref>). After RAW264.7 cells were stimulated with LPS (100&#xa0;ng/ml) for 18&#xa0;h in the presence or absence of <bold>6</bold> and <bold>7</bold>, the levels of TNF-&#x3b1;, IL-6, and MCP-1 in the culture media were measured by the ELISA. As shown in <xref ref-type="fig" rid="F5">Figures 5A&#x2013;C</xref>, compound <bold>6</bold> is able to inhibit the production of the tested cytokines and chemokines in a dose-dependent manner in RAW264.7 cells stimulated with LPS (<italic>p</italic>&#x20;&#x3c; 0.05). Significantly, the protein level of IL-6 is reduced to &#x223c;25% by <bold>6</bold> (40&#xa0;&#x3bc;M), which is comparable to the treatment by DEX (0.5&#xa0;&#x3bc;M). Similar inhibitory effects of <bold>7</bold> could be observed for TNF-&#x3b1; and IL-6, while intriguingly, higher concentrations of <bold>7</bold>, e.g., 20 and 40&#xa0;&#x3bc;M, have no obvious effects on MCP-1 production.</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>Compounds <bold>6</bold> and <bold>7</bold> inhibit the production of inflammatory cytokines and NO, probably through iNOS. Effects of <bold>6 (A</bold>&#x2013;<bold>C)</bold> and <bold>7 (D</bold>&#x2013;<bold>F)</bold> on the protein expression levels of TNF-&#x3b1;, IL-6, and MCP-1 in RAW264.7 cells. The cells were seeded in 12-well plates in a density of 2 &#xd7; 10<sup>5</sup> cells/mL, incubated for 18&#xa0;h and their protein expression were analyzed using the ELISA kit (eBioscience). Effects of <bold>6 (G)</bold> and <bold>7 (H)</bold> on the production of NO in RAW264.7 cells. The cells were pretreated for 1&#xa0;h with the indicated concentrations of <bold>6</bold> or <bold>7</bold> and then stimulated with LPS (100&#xa0;ng/ml) for 24&#xa0;h. NO production in the culture medium was detected using NO detection kit (Invitrogen). The data shown represent the mean values of three independent experiments. &#x2a;<italic>p</italic>&#x20;&#x3c; 0.05, &#x2a;&#x2a;<italic>p</italic>&#x20;&#x3c; 0.01. Molecular docking of <bold>6 (I)</bold> and <bold>7 (J)</bold> with iNOS (PDB ID: 3NW2) using MOE. For clarity, only interacting residues are labeled and hydrogen bonding interactions are shown by dashed arrows.</p>
</caption>
<graphic xlink:href="fchem-09-679592-g005.tif"/>
</fig>
</sec>
<sec id="s3-6">
<title>Anti-Inflammatory Effects of 2-Hydroxy-Alternariol (6) and Alternariol (7) on LPS-Induced NO Production in LPS-Stimulated RAW264.7 Cells</title>
<p>NO, an important cellular messenger, may mediate various biological processes, including inflammation, induction of tumor cell death, and killing alien microorganisms (<xref ref-type="bibr" rid="B25">Jiang et&#x20;al., 2021b</xref>). We next investigated the release of NO by the treatment of <bold>6</bold> and <bold>7</bold> in LPS-stimulated RAW264.7 cells (<xref ref-type="fig" rid="F5">Figures 5G,H</xref>). The level of nitrite, a stable oxidized product of NO in the culture medium of RAW264.7 cells were measured using a nitric oxide detection kit. The treatment with <bold>6</bold> and <bold>7</bold> reduced LPS-induced NO production in a dose-dependent manner in the range of 10&#x2013;40&#xa0;&#x3bc;M. Compound <bold>6</bold> showed stronger inhibition of NO production than <bold>7</bold> in 10&#xa0;&#x3bc;M, consistent with the more potent inhibition of iNOS by&#x20;6.</p>
</sec>
<sec id="s3-7">
<title>Molecular Docking Simulations of 6 and 7 With iNOS</title>
<p>Due to the reduction of NO level and the reduced expression of iNOS by the treatment of <bold>6</bold> and <bold>7</bold> in LPS-treated RAW264.7 cells, compounds <bold>6</bold> and <bold>7</bold> may interact with iNOS and block the biosynthesis of NO. To our knowledge, the dibenzo-&#x03B1;-pyrone scaffold has not been used as iNOS inhibitors. Therefore, the interactions of <bold>6</bold> and <bold>7</bold> with iNOS were investigated using molecular docking by Molecular Operating Environment (MOE) (<xref ref-type="bibr" rid="B20">Hu et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B25">Jiang et&#x20;al., 2021b</xref>). Using the crystal structure of mouse inducible nitric oxide synthase (miNOS, 3NW2) as a template, compound <bold>6</bold> form four hydrogen-bonding interactions with the amino acid residue Trp457, Asp376, and Arg382 of iNOS, while <bold>7</bold> only has one hydrogen-bonding interaction and two &#x3c0;-&#x3c0; interactions with Met428 (<xref ref-type="fig" rid="F5">Figures 5I,J</xref>). Taken together, <bold>6</bold> and <bold>7</bold> may interact with iNOS and could be further developed as specific inhibitors against&#x20;iNOS.</p>
</sec>
</sec>
<sec sec-type="conclusion" id="s4">
<title>Conclusion</title>
<p>In conclusion, five new compounds, including a new dibenzo-&#x3b1;-pyrone derivative, ellagic acid B (<bold>5</bold>) and four new &#x3b1;-pyrone diaporpyrone A&#x2013;D (<bold>9&#x2013;12</bold>), together with three known compounds (<bold>6</bold>&#x2013;<bold>8</bold>), were isolated from the endophytic fungus <italic>Diaporthe</italic> sp. CB10100<italic>.</italic> Their structures were determined by the analyses of their NMR and HRESIMS spectra, while the absolute configuration of <bold>10</bold> and <bold>11</bold> was based on ECD spectra and their specific optical rotations. Ellagic acid B (<bold>5</bold>) features a tetracyclic 6/6/6/6 ring system with a fused 2<italic>H</italic>-chromene, while diaporpyrones consist of a pyrone and a short fatty acid side chain. The biosynthesis of <bold>5</bold> and <bold>8</bold> may involve a fungus PKS similar to SnPKS19 from <italic>P. nodorum</italic>, while the biosynthesis of <bold>9</bold>&#x2013;<bold>12</bold> would likely be catalyzed by distinct fungi PKSs. All of the isolated compounds <bold>5</bold>&#x2013;<bold>12</bold> were evaluated for their anti-inflammatory activities in LPS-stimulated RAW 264.7 macrophages. Among them, <bold>6</bold> and <bold>7</bold> display strong inhibitory activities against iNOS and inhibit nitric oxide production. In addition, both compounds significantly reduced the production of pro-inflammatory mediators and cytokines, including NO, TNF-&#x3b1;, IL-6, and MCP-1. Molecular docking of <bold>6</bold> and <bold>7</bold> to iNOS further suggests that they are potential iNOS inhibitors. Considering the importance of iNOS in inflammation and signal transduction, the discovery of <bold>6</bold> and <bold>7</bold> the alternariol scaffold may be further developed as potential iNOS inhibitors.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="sec" rid="s9">Supplementary Material</xref>.</p>
</sec>
<sec id="s6">
<title>Author Contributions</title>
<p>YH, YD, and HP conceived and designed the experiments. HP, WZ, BH, and CN was responsible for the isolation of compounds. YH and HP elucidated the structures. JL, YP, YT, and XH tested the anti-inflammation of the compounds. YW performed the experiments of docking. YH, YD, and HP interpreted the data and wrote the paper. All authors read and approved the final manuscript.</p>
</sec>
<sec id="s7">
<title>Funding</title>
<p>This work was supported by the NSFC Grants under Grant 81473124 (to YH); the Chinese Ministry of Education 111 Project under Grant BP0820034 (to YD); Hunan Graduate Research and Innovation Grant under Grant CX2018B049 (to HP); Huaihua Science and Technology Project 2018N2203 (to JL) and Hunan University of Medicine High-Level Talent Introduction Startup Funds (to&#x20;JL).</p>
</sec>
<sec sec-type="COI-statement" id="s8">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<ack>
<p>We thank the Center for Advanced Research in Central South University for the NMR experiments. China National Supercomputing Center in Shenzhen for the computation resources.</p>
</ack>
<sec id="s9">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fchem.2021.679592/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fchem.2021.679592/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.PDF" id="SM1" mimetype="application/PDF" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ansari</surname>
<given-names>M. Y.</given-names>
</name>
<name>
<surname>Haqqi</surname>
<given-names>T. M.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Role of iNOS in Osteoarthritis: Pathological and Therapeutic Aspects</article-title>. <source>J.&#x20;Cell. Physiol.</source> <volume>235</volume>, <fpage>6366</fpage>&#x2013;<lpage>6376</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.29607</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Appendino</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Ottino</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Marquez</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Bianchi</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Giana</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Ballero</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Arzanol, an Anti-inflammatory and Anti-HIV-1 Phloroglucinol &#x3b1;-Pyrone from <italic>Helichrysum italicum</italic> ssp. <italic>microphyllum</italic>
</article-title>. <source>J.&#x20;Nat. Prod.</source> <volume>70</volume>, <fpage>608</fpage>&#x2013;<lpage>612</lpage>. <pub-id pub-id-type="doi">10.1021/np060581r</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Brachmann</surname>
<given-names>A. O.</given-names>
</name>
<name>
<surname>Brameyer</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kresovic</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Hitkova</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kopp</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Manske</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Pyrones as Bacterial Signaling Molecules</article-title>. <source>Nat. Chem. Biol.</source> <volume>9</volume>, <fpage>573</fpage>&#x2013;<lpage>578</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.1295</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bruhn</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Schauml&#xf6;ffel</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hemberger</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Bringmann</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>SpecDis: Quantifying the Comparison of Calculated and Experimental Electronic Circular Dichroism Spectra</article-title>. <source>Chirality</source> <volume>25</volume>, <fpage>243</fpage>&#x2013;<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1002/chir.22138</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Buchman</surname>
<given-names>A. L.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Side Effects of Corticosteroid Therapy</article-title>. <source>J.&#x20;Clin. Gastroenterol.</source> <volume>33</volume>, <fpage>289</fpage>&#x2013;<lpage>294</lpage>. <pub-id pub-id-type="doi">10.1097/00004836-200110000-00006</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chapla</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zeraik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ximenes</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Zanardi</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lopes</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Cavalheiro</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Bioactive Secondary Metabolites from <italic>Phomopsis</italic> sp., an Endophytic Fungus from <italic>Senna Spectabilis</italic>
</article-title>. <source>Molecules</source> <volume>19</volume>, <fpage>6597</fpage>&#x2013;<lpage>6608</lpage>. <pub-id pub-id-type="doi">10.3390/molecules19056597</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Deng</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<etal/>
</person-group> (<year>2020</year>). <article-title>Secondary Metabolites with Nitric Oxide Inhibition from Marine-Derived Fungus <italic>Alternaria</italic> sp. 5102</article-title>. <source>Mar. Drugs</source> <volume>18</volume>, <fpage>426</fpage>. <pub-id pub-id-type="doi">10.3390/md18080426</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chepkirui</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Stadler</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>The Genus <italic>Diaporthe</italic>: A Rich Source of Diverse and Bioactive Metabolites</article-title>. <source>Mycol. Prog.</source> <volume>16</volume>, <fpage>477</fpage>&#x2013;<lpage>494</lpage>. <pub-id pub-id-type="doi">10.1007/s11557-017-1288-y</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chomcheon</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Wiyakrutta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sriubolmas</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Ngamrojanavanich</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Mahidol</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Ruchirawat</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Metabolites from the Endophytic Mitosporic <italic>Dothideomycete</italic> sp. LRUB20</article-title>. <source>Phytochemistry</source> <volume>70</volume>, <fpage>121</fpage>&#x2013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1016/j.phytochem.2008.10.007</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chooi</surname>
<given-names>Y.-H.</given-names>
</name>
<name>
<surname>Muria-Gonzalez</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Mead</surname>
<given-names>O. L.</given-names>
</name>
<name>
<surname>Solomon</surname>
<given-names>P. S.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>SnPKS19 Encodes the Polyketide Synthase for Alternariol Mycotoxin Biosynthesis in the Wheat Pathogen <italic>Parastagonospora nodorum</italic>
</article-title>. <source>Appl. Environ. Microbiol.</source> <volume>81</volume>, <fpage>5309</fpage>&#x2013;<lpage>5317</lpage>. <pub-id pub-id-type="doi">10.1128/AEM.00278-15</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choy</surname>
<given-names>E. H. S.</given-names>
</name>
<name>
<surname>Panayi</surname>
<given-names>G. S.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis</article-title>. <source>N. Engl. J.&#x20;Med.</source> <volume>344</volume>, <fpage>907</fpage>&#x2013;<lpage>916</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM200103223441207</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cinelli</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Do</surname>
<given-names>H. T.</given-names>
</name>
<name>
<surname>Miley</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Silverman</surname>
<given-names>R. B.</given-names>
</name>
</person-group> (<year>2020</year>). <article-title>Inducible Nitric Oxide Synthase: Regulation, Structure, and Inhibition</article-title>. <source>Med. Res. Rev.</source> <volume>40</volume>, <fpage>158</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1002/med.21599</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname>Frisch</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Trucks</surname>
<given-names>G. W.</given-names>
</name>
<name>
<surname>Schlegel</surname>
<given-names>H. B.</given-names>
</name>
<name>
<surname>Robb</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Cheeseman</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Scalmani</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <source>Gaussian 09, Revision C.01</source>. <publisher-loc>Wallingford CT</publisher-loc>: <publisher-name>Gaussian, Inc.</publisher-name>
</citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujiwara</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Kobayashi</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>Macrophages in Inflammation</article-title>. <source>Cdtia</source> <volume>4</volume>, <fpage>281</fpage>&#x2013;<lpage>286</lpage>. <pub-id pub-id-type="doi">10.2174/1568010054022024</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guarnaccia</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Crous</surname>
<given-names>P. W.</given-names>
</name>
</person-group> (<year>2017</year>). <article-title>Emerging Citrus Diseases in Europe Caused by Species of <italic>Diaporthe</italic>
</article-title>. <source>IMA Fungus</source> <volume>8</volume>, <fpage>317</fpage>&#x2013;<lpage>334</lpage>. <pub-id pub-id-type="doi">10.5598/imafungus.2017.08.02.07</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hildebrand</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Kohn</surname>
<given-names>B. N.</given-names>
</name>
<name>
<surname>Pfeiffer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Wefers</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Metzler</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Bunzel</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Conjugation of the Mycotoxins Alternariol and Alternariol Monomethyl Ether in Tobacco Suspension Cells</article-title>. <source>J.&#x20;Agric. Food Chem.</source> <volume>63</volume>, <fpage>4728</fpage>&#x2013;<lpage>4736</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jafc.5b00806</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hou</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Ju</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Overexpression of a Type III PKS Gene Affording Novel Violapyrones with Enhanced Anti-influenza A Virus Activity</article-title>. <source>Microb. Cell Fact.</source> <volume>17</volume>, <fpage>1</fpage>&#x2013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1186/s12934-018-0908-9</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hu</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Xie</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Guo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>X.-N.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Phomopsterones A and B, Two Functionalized Ergostane-Type Steroids from the Endophytic Fungus <italic>Phomopsis</italic> sp. TJ507A</article-title>. <source>Org. Lett.</source> <volume>19</volume>, <fpage>258</fpage>&#x2013;<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1021/acs.orglett.6b03557</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Huang</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Hou</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Dewdney</surname>
<given-names>M. M.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Hyde</surname>
<given-names>K. D.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>
<italic>Diaporthe</italic> Species Occurring on Citrus in China</article-title>. <source>Fungal Divers.</source> <volume>61</volume>, <fpage>237</fpage>&#x2013;<lpage>250</lpage>. <pub-id pub-id-type="doi">10.1007/s13225-013-0245-6</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wen</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.</given-names>
</name>
<etal/>
</person-group> (<year>2021a</year>). <article-title>Syn-2, 3-diols and anti-inflammatory Indole Derivatives from <italic>Streptomyces</italic> sp. CB09001</article-title>. <source>Nat. Prod. Res.</source> <volume>35</volume>, <fpage>144</fpage>&#x2013;<lpage>151</lpage>. <pub-id pub-id-type="doi">10.1080/14786419.2019.1611812</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Pu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Xiang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Su</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yang</surname>
<given-names>D.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Huanglongmycin A-C, Cytotoxic Polyketides Biosynthesized by a Putative Type II Polyketide Synthase from <italic>Streptomyces</italic> sp. CB09001</article-title>. <source>Front. Chem.</source> <volume>6</volume>, <fpage>1</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.3389/fchem.2018.00254</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Jiang</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Yin</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qi</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Song</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>W.</given-names>
</name>
</person-group> (<year>2021b</year>). <article-title>Immunomodulatory Effects of Fucosylated Chondroitin Sulfate from <italic>Stichopus Chloronotus</italic> on RAW 264.7 Cells</article-title>. <source>Carbohydr. Polym.</source> <volume>251</volume>, <fpage>117088</fpage>. <pub-id pub-id-type="doi">10.1016/j.carbpol.2020.117088</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>G. S.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>J.&#x20;W.</given-names>
</name>
<name>
<surname>Jeong</surname>
<given-names>M.-H.</given-names>
</name>
<name>
<surname>Ko</surname>
<given-names>S.-K.</given-names>
</name>
<name>
<surname>Hur</surname>
<given-names>J.-S.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Bioactive &#x3b1;-Pyrone Derivatives from the Endolichenic Fungus <italic>Dothideomycetes</italic> sp. EL003334</article-title>. <source>J.&#x20;Nat. Prod.</source> <volume>81</volume>, <fpage>1084</fpage>&#x2013;<lpage>1088</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.7b01022</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kim</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Sohn</surname>
<given-names>M.-J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>C.-J.</given-names>
</name>
<name>
<surname>Kwon</surname>
<given-names>H. J.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>W.-G.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Verrulactones A and B, New Inhibitors of <italic>Staphylococcus aureus</italic> Enoyl-ACP Reductase Produced by <italic>Penicillium verruculosum</italic> F375</article-title>. <source>Bioorg. Med. Chem. Lett.</source> <volume>22</volume>, <fpage>2503</fpage>&#x2013;<lpage>2506</lpage>. <pub-id pub-id-type="doi">10.1016/j.bmcl.2012.02.001</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ku</surname>
<given-names>K.-T.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.-L.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>Y.-J.</given-names>
</name>
<name>
<surname>Chiou</surname>
<given-names>W.-F.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Miyabenol A Inhibits LPS-Induced NO Production via IKK/I&#x3ba;B Inactivation in RAW 264.7 Macrophages: Possible Involvement of the P38 and PI3K Pathways</article-title>. <source>J.&#x20;Agric. Food Chem.</source> <volume>56</volume>, <fpage>8911</fpage>&#x2013;<lpage>8918</lpage>. <pub-id pub-id-type="doi">10.1021/jf8019369</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kyoung</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rak</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Min</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Moon</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Bioactivity-Based Analysis and Chemical Characterization of Anti-inflammatory Compounds from <italic>Curcuma Zedoaria</italic> Rhizomes Using LPS-Stimulated RAW264.7 Cells</article-title>. <source>Bioorg. Chem.</source> <volume>82</volume>, <fpage>26</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2018.09.027</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Laavola</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Nieminen</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Lepp&#xe4;nen</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Eckerman</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Holmbom</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Moilanen</surname>
<given-names>E.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Pinosylvin and Monomethylpinosylvin, Constituents of an Extract from the Knot of Pinus Sylvestris, Reduce Inflammatory Gene Expression and Inflammatory Responses <italic>in vivo</italic>
</article-title>. <source>J.&#x20;Agric. Food Chem.</source> <volume>63</volume>, <fpage>3445</fpage>&#x2013;<lpage>3453</lpage>. <pub-id pub-id-type="doi">10.1021/jf504606m</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Bioactive Dibenzo-&#x3b1;-Pyrone Derivatives from the Endophytic Fungus <italic>Rhizopycnis Vagum</italic> Nitaf22</article-title>. <source>J.&#x20;Nat. Prod.</source> <volume>79</volume>, <fpage>2022</fpage>&#x2013;<lpage>2031</lpage>. <pub-id pub-id-type="doi">10.1021/acs.jnatprod.6b00327</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zuo</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Stauntoside B Inhibits Macrophage Activation by Inhibiting NF-&#x39a;b and ERK MAPK Signalling</article-title>. <source>Pharmacol. Res.</source> <volume>111</volume>, <fpage>303</fpage>&#x2013;<lpage>315</lpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2016.06.022</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mao</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Fu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Lai</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>L.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>Natural Dibenzo-&#x3b1;-Pyrones and Their Bioactivities</article-title>. <source>Molecules</source> <volume>19</volume>, <fpage>5088</fpage>&#x2013;<lpage>5108</lpage>. <pub-id pub-id-type="doi">10.3390/molecules19045088</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mcglacken</surname>
<given-names>G. P.</given-names>
</name>
<name>
<surname>Fairlamb</surname>
<given-names>I. J.&#x20;S.</given-names>
</name>
</person-group> (<year>2005</year>). <article-title>2-Pyrone Natural Products and Mimetics: Isolation, Characterisation and Biological Activity</article-title>. <source>Nat. Prod. Rep.</source> <volume>22</volume>, <fpage>369</fpage>&#x2013;<lpage>385</lpage>. <pub-id pub-id-type="doi">10.1039/b416651p</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pfeiffer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Schebb</surname>
<given-names>N. H.</given-names>
</name>
<name>
<surname>Podlech</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Metzler</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Novel Oxidative <italic>in&#x20;vitro</italic> Metabolites of the Mycotoxins Alternariol and Alternariol Methyl Ether</article-title>. <source>Mol. Nutr. Food Res.</source> <volume>51</volume>, <fpage>307</fpage>&#x2013;<lpage>316</lpage>. <pub-id pub-id-type="doi">10.1002/mnfr.200600237</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Purkayastha</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Cai</surname>
<given-names>D.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Neuroinflammatory Basis of Metabolic Syndrome</article-title>. <source>Mol. Metab.</source> <volume>2</volume>, <fpage>356</fpage>&#x2013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1016/j.molmet.2013.09.005</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>R&#xed;os</surname>
<given-names>J.-L.</given-names>
</name>
<name>
<surname>Giner</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Mar&#xed;n</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Recio</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A Pharmacological Update of Ellagic Acid</article-title>. <source>Planta Med.</source> <volume>84</volume>, <fpage>1068</fpage>&#x2013;<lpage>1093</lpage>. <pub-id pub-id-type="doi">10.1055/a-0633-9492</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rivera-Ch&#xe1;vez</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>El-Elimat</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Gallagher</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Graf</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Fournier</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Panigrahi</surname>
<given-names>G.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Delitpyrones: &#x3b1;-Pyrone Derivatives from a Freshwater <italic>Delitschia</italic> sp</article-title>. <source>Planta Med.</source> <volume>85</volume>, <fpage>62</fpage>&#x2013;<lpage>71</lpage>. <pub-id pub-id-type="doi">10.1055/a-0654-5850</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Salvo</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Fourrier-R&#xe9;glat</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Bazin</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Robinson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Riera-Guardia</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Haag</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2011</year>). <article-title>Cardiovascular and Gastrointestinal Safety of NSAIDs: A Systematic Review of Meta-Analyses of Randomized Clinical Trials</article-title>. <source>Clin. Pharmacol. Ther.</source> <volume>89</volume>, <fpage>855</fpage>&#x2013;<lpage>866</lpage>. <pub-id pub-id-type="doi">10.1038/clpt.2011.45</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Solhaug</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Wisbech</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Christoffersen</surname>
<given-names>T. E.</given-names>
</name>
<name>
<surname>Hult</surname>
<given-names>L. O.</given-names>
</name>
<name>
<surname>Lea</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Eriksen</surname>
<given-names>G. S.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>The Mycotoxin Alternariol Induces DNA Damage and Modify Macrophage Phenotype and Inflammatory Responses</article-title>. <source>Toxicol. Lett.</source> <volume>239</volume>, <fpage>9</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1016/j.toxlet.2015.08.1107</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>R. X.</given-names>
</name>
<name>
<surname>Zou</surname>
<given-names>W. X.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Endophytes: a Rich Source of Functional Metabolites (1987 to 2000)</article-title>. <source>Nat. Prod. Rep.</source> <volume>18</volume>, <fpage>448</fpage>&#x2013;<lpage>459</lpage>. <pub-id pub-id-type="doi">10.1039/b100918o</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Wang</surname>
<given-names>L.-J.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Z.-M.</given-names>
</name>
<name>
<surname>Xiao</surname>
<given-names>P.-T.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>J.-B.</given-names>
</name>
<name>
<surname>Bi</surname>
<given-names>Z.-M.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>E.-H.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Identification of Anti-Inflammatory Components in <italic>Sinomenii Caulis</italic> Based on Spectrum-Effect Relationship and Chemometric Methods</article-title>. <source>J.&#x20;Pharm. Biomed. Anal.</source> <volume>167</volume>, <fpage>38</fpage>&#x2013;<lpage>48</lpage>. <pub-id pub-id-type="doi">10.1016/j.jpba.2019.01.047</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yu</surname>
<given-names>C.-H.</given-names>
</name>
<name>
<surname>Suh</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E.-H.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>Y.-J.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Inhibitory Effects of a Novel Chrysin-Derivative, CPD 6, on Acute and Chronic Skin Inflammation</article-title>. <source>Int. J.&#x20;Mol. Sci.</source> <volume>20</volume>, <fpage>2607</fpage>. <pub-id pub-id-type="doi">10.3390/ijms20112607</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>D. W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>R. D.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>L. Y.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>[A New Lactone Derivative from Plant Endophytic Fungus <italic>Periconia</italic> sp. F-31]</article-title>. <source>Zhongguo Zhong Yao Za Zhi</source> <volume>40</volume>, <fpage>2349</fpage>&#x2013;<lpage>2351</lpage>. <pub-id pub-id-type="doi">10.4268/cjcmm20151217</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Jiang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2013</year>). <article-title>Violapyrones A-G, &#x3b1;-Pyrone Derivatives from <italic>Streptomyces Violascens</italic> Isolated from <italic>Hylobates hoolock</italic> Feces</article-title>. <source>J.&#x20;Nat. Prod.</source> <volume>76</volume>, <fpage>2126</fpage>&#x2013;<lpage>2130</lpage>. <pub-id pub-id-type="doi">10.1021/np4003417</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>X.-X.</given-names>
</name>
<name>
<surname>Peng</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Qin</surname>
<given-names>L.-P.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>
<italic>Sinomenium Acutum</italic>: A Review of Chemistry, Pharmacology, Pharmacokinetics, and Clinical Use</article-title>. <source>Pharm. Biol.</source> <volume>50</volume>, <fpage>1053</fpage>&#x2013;<lpage>1061</lpage>. <pub-id pub-id-type="doi">10.3109/13880209.2012.656847</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhong</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Sanchez-lopez</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Karin</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Autophagy, Inflammation, and Immunity: A Troika Governing Cancer and its Treatment</article-title>. <source>Cell</source> <volume>166</volume>, <fpage>288</fpage>&#x2013;<lpage>298</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2016.05.051</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhu</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yan</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>An</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Huo</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>T.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>&#x3b1;-Pyrones, Secondary Metabolites from Fungus <italic>Cephalotrichum Microsporum</italic> and Their Bioactivities</article-title>. <source>Bioorg. Chem.</source> <volume>83</volume>, <fpage>129</fpage>&#x2013;<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1016/j.bioorg.2018.10.022</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>